Arranta Bio MA, LLC.
Watertown, Massachusetts, United States
Purpose
To develop an AI-based continuous manufacturing platform for RNA vaccines to improve affordability and access for low- and -middle income countries.
Division
Global Health
Date
September 2025
Region Served
GLOBAL
Committed amount
$3,090,161
Grant topic
Vaccine Development
Duration (months)
21
Grantee location
Watertown, Massachusetts, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.